Ferring Pharmaceuticals
Clinical trials sponsored by Ferring Pharmaceuticals, explained in plain language.
-
New fertility drug combo aims to boost IVF success, but trial halted early
Disease control TerminatedThis early-stage study tested whether adding the drug FE999302 to standard fertility treatment (follitropin delta) could improve the number of high-quality embryos in women undergoing ovarian stimulation for IVF. The trial enrolled about 310 women aged 18-40 with normal ovarian r…
Phase: PHASE1 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:14 UTC
-
Bladder cancer drug adstiladrin under Real-World watch
Disease control TerminatedThis study looked at how well the drug Adstiladrin works for people with bladder cancer when used in normal medical practice, not in a strict research setting. It included 202 adults who were prescribed the drug by their doctor. The main goal was to see if the cancer disappeared …
Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
Timing of fertility drug may affect egg quality in IVF
Disease control TerminatedThis early-stage study tested whether giving an extra fertility drug (FE 999302) at different times during ovarian stimulation could improve the number of good-quality embryos in women with infertility. The trial enrolled 106 women and compared the drug to a placebo. The study wa…
Phase: PHASE1 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:48 UTC